← Evidence map

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2025

The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022.

Jane R Schubart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39790860